SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-059570
Filing Date
2024-05-14
Accepted
2024-05-14 16:15:18
Documents
13
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K evok-20240514.htm   iXBRL 8-K 40624
2 EX-99.1 evok-ex99_1.htm EX-99.1 187242
3 GRAPHIC img208171256_0.jpg GRAPHIC 27817
  Complete submission text file 0000950170-24-059570.txt   390407

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20240514.xsd EX-101.SCH 23902
16 EXTRACTED XBRL INSTANCE DOCUMENT evok-20240514_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 24944527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)